Contact
searchSearch
HMP Global

News

News
Capsules Recalled for Unknown Impurity
02/15/2024
Amneal Pharmaceuticals of New York is recalling 858 bottles of phenoxybenzamine hydrochloride capsules because they are out of specification for an unknown impurity, according to the February 14, 2024, US Food and Drug Administration (FDA)...
Amneal Pharmaceuticals of New York is recalling 858 bottles of phenoxybenzamine hydrochloride capsules because they are out of specification for an unknown impurity, according to the February 14, 2024, US Food and Drug Administration (FDA)...
Amneal Pharmaceuticals of New...
02/15/2024
Pharmacy Learning Network
News
Class I Recall for Dozens of OTC Eye Drops
02/14/2024
Sterility concerns due to unsanitary manufacturing conditions have prompted the US Food and Drug Administration (FDA) to issue a Class I designation for a recall spanning 27 over-the-counter eye drops sold by various retailers throughout the...
Sterility concerns due to unsanitary manufacturing conditions have prompted the US Food and Drug Administration (FDA) to issue a Class I designation for a recall spanning 27 over-the-counter eye drops sold by various retailers throughout the...
Sterility concerns due to...
02/14/2024
Pharmacy Learning Network
News
Superpotency Concerns Prompt Recall of IV Hypotension Drug
02/09/2024
The US Food and Drug Administration (FDA) has issued a Class I designation for the recall of more than 41,000 bags of intravenous (IV) phenylephrine hydrochloride from Leiters Health, according to the February 7, 2024, FDA Enforcement Report....
The US Food and Drug Administration (FDA) has issued a Class I designation for the recall of more than 41,000 bags of intravenous (IV) phenylephrine hydrochloride from Leiters Health, according to the February 7, 2024, FDA Enforcement Report....
The US Food and Drug...
02/09/2024
Pharmacy Learning Network
News
IV Antibiotic Under Class I Recall
02/09/2024
An equipment malfunction that may have led to drug superpotency has prompted Denver Solutions, which does business as Leiters Health, to recall approximately 17,000 bags of intravenous (IV) vancomycin hydrochloride, according to the February...
An equipment malfunction that may have led to drug superpotency has prompted Denver Solutions, which does business as Leiters Health, to recall approximately 17,000 bags of intravenous (IV) vancomycin hydrochloride, according to the February...
An equipment malfunction that...
02/09/2024
Pharmacy Learning Network
News
Class I Recall for IV Analgesic
02/08/2024
Nearly 23,000 bags of intravenous (IV) fentanyl citrate from Leiters Health are under a Class I recall for potential superpotency. According to the February 7, 2024, US Food and Drug Administration (FDA) Enforcement Report, the IV bags may...
Nearly 23,000 bags of intravenous (IV) fentanyl citrate from Leiters Health are under a Class I recall for potential superpotency. According to the February 7, 2024, US Food and Drug Administration (FDA) Enforcement Report, the IV bags may...
Nearly 23,000 bags of...
02/08/2024
Pharmacy Learning Network
News
Clinic Closure Hampers Methadone Access for More than 1000
02/02/2024
Extensive damage from a frozen pipe that burst forced the closure of Washington state’s largest single-site methadone treatment provider in January. While it makes repairs at its Seattle-based clinic, Evergreen Treatment Services is shuttling...
Extensive damage from a frozen pipe that burst forced the closure of Washington state’s largest single-site methadone treatment provider in January. While it makes repairs at its Seattle-based clinic, Evergreen Treatment Services is shuttling...
Extensive damage from a frozen...
02/02/2024
Pharmacy Learning Network
News
Ear Drops Recalled
02/01/2024
Nearly 40,000 bottles of fluocinolone acetonide oil are being recalled by Glenmark Pharmaceuticals Inc. USA for failing to meet excipient specifications, according to the January 31, 2024, US Food and Drug Administration (FDA) Enforcement...
Nearly 40,000 bottles of fluocinolone acetonide oil are being recalled by Glenmark Pharmaceuticals Inc. USA for failing to meet excipient specifications, according to the January 31, 2024, US Food and Drug Administration (FDA) Enforcement...
Nearly 40,000 bottles of...
02/01/2024
Pharmacy Learning Network
News
Photochemotherapy Capsules Recalled
02/01/2024
Strides Pharma Inc. is recalling 396 bottles of methoxsalen capsules because samples failed to meet dissolution specifications during routine testing, according to the January 31, 2024, US Food and Drug Administration (FDA) Enforcement...
Strides Pharma Inc. is recalling 396 bottles of methoxsalen capsules because samples failed to meet dissolution specifications during routine testing, according to the January 31, 2024, US Food and Drug Administration (FDA) Enforcement...
Strides Pharma Inc. is recalling...
02/01/2024
Pharmacy Learning Network
News
Opioid Settlement Accountability Act: Addressing Oversight Challenges and Ensuring Effective Fund Utilization
02/01/2024
In response to the growing concern over the use of opioid settlement funds, some members of Congress are calling for federal oversight to ensure the billions distributed to state and local governments are used effectively to combat the opioid...
In response to the growing concern over the use of opioid settlement funds, some members of Congress are calling for federal oversight to ensure the billions distributed to state and local governments are used effectively to combat the opioid...
In response to the growing...
02/01/2024
Pharmacy Learning Network
News
Class I Recall for Cancer Drug
01/31/2024
A Class I recall has been issued for 3546 vials of bleomycin for injection distributed by Hospira Inc., a Pfizer company, according to the January 31, 2024, US Food and Drug Administration (FDA) Enforcement Report. The recall was initiated...
A Class I recall has been issued for 3546 vials of bleomycin for injection distributed by Hospira Inc., a Pfizer company, according to the January 31, 2024, US Food and Drug Administration (FDA) Enforcement Report. The recall was initiated...
A Class I recall has been issued...
01/31/2024
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use